Genfit shares rise 5.3% on nangibotide clinical data
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Finance & Markets
AUD/NZD Price Forecast: Aussie falls below 1.2300, nearing two-month lows at 1.2265
The Aussie Dollar (AUD) accelerated its decline against a stronger New Zealand Dollar (NZD) on Monday, as provisional results from New Zealand’s general election gave the governing coalition a tight…
Stockbrokers urge capital market to finance real economy
The Chartered Institute of Stockbrokers (CIS) has urged capital market operators, regulators and policymakers to channel more investments into Nigeria's productive economy, as the 10 largest companies…
Italy’s Agnellis Divest Further With $700 Million CNH Stake Sale
CNH Industrial NV agreed to sell 70% of its construction equipment business to a unit of Japan’s Kobe Steel, furthering efforts by Italy’s Fiat-founding Agnelli family to streamline its industrial…
Russia’s Japan Tobacco Grab Is Risk for Takaichi’s Spending Plan
Russia’s seizure of Japan Tobacco Inc.’s local assets risks reducing the Japanese government’s pool of spending money just as Prime Minister Sanae Takaichi pushes a costly policy agenda.
